Active ingredientCarbidopaCat. No. P-C037-001CAS 38821-49-7Family · Pharmaceutical analytical standards
Carbidopa
A dopa decarboxylase inhibitor that does not enter the brain: combined with levodopa for Parkinson's disease, in a combination approved in the United States in 1975, it stops levodopa from turning into dopamine before it reaches the brain. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was born in the 1960s among analogues of methyldopa, a blood-pressure medicine; given with levodopa, it extends levodopa's half-life in the blood from about 50 minutes to an hour and a half.
Go to the active ingredient →Active ingredientCarbidopaCat. No. P-C037-001CAS 38821-49-7
Pharmacopoeial impurityCarbidopa EP Impurity B HydrochlorideCat. No. P-C037-002CAS 115054-62-1
Pharmacopoeial impurityCarbidopa EP Impurity BCat. No. P-C037-003CAS 18181-08-3
Pharmacopoeial impurityCarbidopa EP Impurity CCat. No. P-C037-004CAS 84488-77-7
Pharmacopoeial impurityCarbidopa EP Impurity C (as Racemate)Cat. No. P-C037-005CAS 85933-19-3
Pharmacopoeial impurityCarbidopa EP Impurity DCat. No. P-C037-006CAS 934371-48-9
Pharmacopoeial impurityCarbidopa EP Impurity ECat. No. P-C037-007CAS 52514-63-3
Pharmacopoeial impurityCarbidopa EP Impurity FCat. No. P-C037-008CAS 1458640-32-8
Pharmacopoeial impurityCarbidopa EP Impurity GCat. No. P-C037-009CAS 2503-44-8
Pharmacopoeial impurityCarbidopa EP Impurity HCat. No. P-C037-010CAS 1361017-74-4
Pharmacopoeial impurityCarbidopa EP Impurity J (Racemic)Cat. No. P-C037-011CAS 1246817-47-9
Pharmacopoeial impurityCarbidopa EP Impurity JCat. No. P-C037-012CAS 43197-33-7
Pharmacopoeial impurityrac-Carbidopa EP Impurity C TrifluoroacetateCat. No. P-C037-013
Pharmacopoeial impurityrac-Carbidopa EP Impurity FCat. No. P-C037-014CAS 91908-71-3
Pharmacopoeial impurityrac-Carbidopa EP Impurity F HydrochlorideCat. No. P-C037-015CAS 96115-88-7
Pharmacopoeial impurityrac-Carbidopa EP Impurity ICat. No. P-C037-016CAS 1246819-09-9
Isotopically labelledCarbidopa-d3Cat. No. P-C037-017CAS 1276732-89-8
Isotopically labelledCarbidopa-d6Cat. No. P-C037-018
NitrosamineN-Nitroso CarbidopaCat. No. P-C037-020
Impurity(R)-CarbidopaCat. No. P-C037-021CAS 28875-92-5
Active ingredient(S)-(-)-CarbidopaCat. No. P-C037-022CAS 28860-95-9
Impurity1-(3,4-Dimethoxyphenyl)propan-2-oneCat. No. P-C037-023CAS 776-99-8
Impurity3,4-O,O-Dimethyl CarbidopaCat. No. P-C037-024CAS 28860-96-0
ImpurityCarbidopa Impurity 1Cat. No. P-C037-025CAS 53832-94-3
ImpurityCarbidopa hydantoic acidCat. No. P-C037-026CAS 28861-00-9
ImpurityCarbidopa Impurity 2 HydrobromideCat. No. P-C037-027
ImpurityCarbidopa Impurity 3Cat. No. P-C037-028
ImpurityCarbidopa Methyl EsterCat. No. P-C037-030CAS 91431-01-5
ImpurityD,L-CarbidopaCat. No. P-C037-031CAS 302-53-4
Impurityrac-Carbidopa Impurity HCat. No. P-C037-032No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceCarbidopa CRSEDQM code C0460000Family CarbidopaNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.